Related Experiment Videos
[Postoperative agitation. A new cause]
1Service d'Anesthésie et de Réanimation, Hôpital Beaujon, Clichy.
Cahiers D'Anesthesiologie
|November 1, 1988
Summary
Postoperative confusion and restlessness in patients may indicate benzodiazepine (BZD) withdrawal syndrome. Gradual BZD reduction is the most effective management strategy.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Context:
- Postoperative confusion and restlessness are common complications following surgical procedures.
- Benzodiazepines (BZD) are frequently used for sedation and anxiety management in perioperative settings.
- Identifying the etiology of postoperative agitation is crucial for appropriate patient care.
Purpose:
- To analyze the occurrence and characteristics of benzodiazepine (BZD) withdrawal syndrome in postoperative patients.
- To differentiate BZD withdrawal from other causes of postoperative agitation.
- To evaluate management strategies for BZD withdrawal syndrome in this population.
Summary:
- Thirty-three postoperative patients exhibiting confusion and restlessness were studied.
- Two groups were identified: those with prior regular BZD use and those receiving high-dose BZD postoperatively.
- Symptoms included anxiety, restlessness, myoclonus, delirium, coma, and seizures, appearing 1-5 days after BZD withdrawal. Diagnosis was confirmed by BZD administration and plasma levels.
- Severity correlated with BZD dose and duration. Propranolol was considered, but progressive BZD withdrawal was deemed the optimal management.
Impact:
- Highlights the potential for benzodiazepine withdrawal syndrome in postoperative patients.
- Emphasizes the importance of considering BZD withdrawal in the differential diagnosis of postoperative agitation.
- Recommends gradual BZD tapering as the preferred management approach, potentially improving patient outcomes and reducing complications.